CAMP4 Therapeutics Corporation
NASDAQ:CAMPBiotechnology
+$0.10 today
- Market cap
- $251.02M
- Beta
- 0.08
- P/E (TTM)
- -2.8
- EPS (TTM)
- -$1.49
Volume 0.21M
Average 0.10M
Dividends
CAMP4 Therapeutics Corporation dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
—
Shareholder Yield
0.00%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 0.0%, so compare payout growth against earnings coverage.
Competitor dividends
How does CAMP4 Therapeutics Corporation compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
ALX Oncology Holdings Inc. NASDAQ:ALXO | $143.81M | 0.00% | $0.00 | 0.00% | 0.00% |
Unicycive Therapeutics, Inc. NASDAQ:UNCY | $97.25M | 0.00% | $0.00 | 0.00% | 0.00% |
Vaxart, Inc. NASDAQ:VXRT | $90.17M | 0.00% | $0.00 | 0.00% | 0.00% |
PMV Pharmaceuticals, Inc. NASDAQ:PMVP | $67.73M | 0.00% | $0.00 | 0.00% | 0.00% |
Acrivon Therapeutics, Inc. Common Stock NASDAQ:ACRV | $62.14M | 0.00% | $0.00 | 0.00% | 0.00% |
MindWalk Holdings Corp. NASDAQ:HYFT | $47.10M | 0.00% | $0.00 | 0.00% | 0.25% |
Biomea Fusion, Inc. NASDAQ:BMEA | $42.31M | 0.00% | $0.00 | 0.00% | 0.00% |
aTyr Pharma, Inc. NASDAQ:ATYR | $14.97M | 0.00% | $0.00 | 0.00% | 0.00% |
Questions
Dividend questions
Common questions about CAMP's dividend, answered from reported figures.
Does CAMP stock pay dividends?
CAMP4 Therapeutics Corporation (CAMP) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is CAMP's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.